Claritev (CTEV) Non Operating Investment Income (2020 - 2022)

Claritev (CTEV) recorded quarterly Non Operating Investment Income of $289000.0 in Q1 2022, up 1056.0% quarter-over-quarter from $25000.0 in Q2 2021.

Claritev (CTEV) Non Operating Investment Income (2020 - 2022) Analysis & Trends

Claritev's Non Operating Investment Income history runs 3 years deep, the most recent figure standing at $289000.0 for Q1 2022.

  • In Q1 2022, Non Operating Investment Income changed N/A year-over-year to $289000.0; the TTM figure through Dec 2022 stood at $289000.0 (up 1056.0% YoY), while the FY2022 annual figure was $289000.0, up 1056.0% from the prior year.
  • Non Operating Investment Income was $289000.0 for Q1 2022 at Claritev, up from $25000.0 in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $2.2 million in Q1 2020 to a low of -$7.8 million in Q3 2020.
  • Historically, Non Operating Investment Income has averaged -$1.9 million across 3 years, with a median of $25000.0 in 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Veeva Systems 26.11 Bn 18.79 Bn 662.02 Mn -
2 BrightSpring Health Services 12.95 Bn 12.07 Bn 482.22 Mn -
3 Healthequity 7.46 Bn 7.19 Bn 256.31 Mn -
4 Hinge Health 5.15 Bn 4.83 Bn 154.23 Mn -
5 Doximity 3.75 Bn 3.00 Bn 125.97 Mn -
6 10x Genomics 3.69 Bn 3.15 Bn 106.18 Mn -
7 Waystar Holding 3.61 Bn 3.45 Bn 268.04 Mn -
8 Privia Health 2.90 Bn 2.54 Bn 595.71 Mn -
9 Omnicell 1.72 Bn 1.54 Bn 140.36 Mn -
10 Claritev 524.72 Mn 496.72 Mn 175.60 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 289,000.00
Mar 31, 2022 289,000.00
Jun 30, 2021 25,000.00
Jun 30, 2021 25,000.00
Dec 31, 2020 -4.38 Mn
Dec 31, 2020 -4.38 Mn
Sep 30, 2020 -7.78 Mn
Sep 30, 2020 -7.78 Mn
Mar 31, 2020 2.23 Mn
Mar 31, 2020 2.23 Mn